Literature DB >> 30354355

Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.

Tze-Fan Chao1,2, Chern-En Chiang1,3,2, Yenn-Jiang Lin1,2, Shih-Lin Chang1,2, Li-Wei Lo1,2, Yu-Feng Hu1,2, Ta-Chuan Tuan1,2, Jo-Nan Liao1,2, Fa-Po Chung1,2, Tzeng-Ji Chen4, Gregory Y H Lip5, Shih-Ann Chen1,2.   

Abstract

Entities:  

Keywords:  NOACs; atrial fibrillation; ischemic stroke; mortality

Mesh：

Substances：

Year:  2018        PMID： 30354355     DOI： 10.1161/CIRCULATIONAHA.118.036046

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Health Economics of Stroke Prevention in Atrial Fibrillation.

Authors:  Kang-Ling Wang; Chern-En Chiang
Journal:  Acta Cardiol Sin       Date:  2020-01       Impact factor: 2.672

2.  Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis.

Authors:  Xiaoyue Jia; Xi Cheng; Na Wu; Ying Xiang; Long Wu; Bin Xu; Chengying Li; Zhihui Zhang; Shifei Tong; Li Zhong; Yafei Li
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

3.  Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.

Authors:  Hsuan-Li Huang; Shang-Hung Chang; Chun-Li Wang; Victor Chien-Chia Wu; Hui-Tzu Tu; Yu-Tung Huang; Shao-Wei Chen; Pao-Hsien Chu; Ming-Shien Wen
Journal:  J Thromb Thrombolysis       Date:  2021-09-23       Impact factor: 2.300

4.  Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants.

Authors:  Jo-Nan Liao; Yi-Hsin Chan; Ling Kuo; Chuan-Tsai Tsai; Su-Shen Lim; Tze-Fan Chao
Journal:  Front Cardiovasc Med       Date:  2022-07-05

5.  Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation.

Authors:  So-Ryoung Lee; Eue-Keun Choi; Sang-Hyeon Park; Seung-Woo Lee; Kyung-Do Han; Seil Oh; Gregory Y H Lip
Journal:  Front Cardiovasc Med       Date:  2022-07-04

6.  Net clinical benefit of non-vitamin K antagonist oral anticoagulants in atrial fibrillation and chronic kidney disease: a trade-off analysis from four phase III clinical trials.

Authors:  Zhi-Chun Gu; Ling-Cong Kong; Shuo-Fei Yang; An-Hua Wei; Na Wang; Zheng Ding; Chi Zhang; Xiao-Yan Liu; Ying-Li Zheng; Hou-Wen Lin
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 7.  Safety of antithrombotic therapy in East Asian patients.

Authors:  Shinya Goto; Shinichi Goto
Journal:  Intern Emerg Med       Date:  2021-03-08       Impact factor: 3.397

8.  Variations of risk factors for ischemic stroke and its subtypes in Chinese patients in Taiwan.

Authors:  Chung-Fen Tsai; Cathie L M Sudlow; Niall Anderson; Jiann-Shing Jeng
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

9.  Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study.

Authors:  So-Ryoung Lee; Eue-Keun Choi; Seo-Young Lee; Euijae Lee; Kyung-Do Han; Myung-Jin Cha; Woon Yong Kwon; Sang Do Shin; Seil Oh; Gregory Y H Lip
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

Review 10.  A narrative review of evidence to guide deprescribing among older adults.

Authors:  Kenya Ie; Shuichi Aoshima; Taku Yabuki; Steven M Albert
Journal:  J Gen Fam Med       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.